文献速递呼吸衰竭与机械通气心脑血管急症重症综合管理与镇静镇痛

医院病例量与急性肺栓塞结局:跨国基于人群的队列研究

Hospital volume and outcomes for acute pulmonary embolism: multinational population based cohort study.
PubMed 文献 · BMJ · 2019-07-29
一句话结论急性症状性肺栓塞患者收治于年肺栓塞例数>40例的高容量医院,30天肺栓塞相关死亡调整比值比降低44%,但全因死亡无显著差异。

该跨国基于人群队列研究利用RIETE登记库2001年1月1日至2018年8月31日数据,纳入16个国家353家医院连续39 257例确诊急性症状性肺栓塞患者,评估医院年肺栓塞病例量与30天肺栓塞相关死亡的关系。高容量医院(>40例/年)患者合并症负担更高,但年病例量与肺栓塞相关死亡呈显著负相关:最高四分位(>40例/年)较最低四分位(<15例/年)调整后30天肺栓塞相关死亡风险降低44%(调整风险1.3% vs 2.3%;调整比值比0.56,95%CI 0.33-0.95;P=0.03)。30天全因死亡无显著降低(调整比值比0.78,95%CI 0.50-1.22;P=0.28);幸存者复发静脉血栓栓塞(比值比0.76,95%CI 0.49-1.19)和大出血(比值比1.07,95%CI 0.77-1.47)无显著差异。作者认为这些发现可能对管理策略有启示。

要点

  • 急性症状性肺栓塞患者收治于年肺栓塞例数>40例的高容量医院,30天肺栓塞相关死亡调整比值比0.56(95%CI 0.33-0.95;P=0.03),较低容量医院(<15例/年)降低44%。
  • 高容量医院(>40例/年)调整后30天肺栓塞相关死亡风险1.3%,低容量医院(<15例/年)为2.3%。
  • 30天全因死亡在高容量与低容量医院间无显著差异(调整比值比0.78,95%CI 0.50-1.22;P=0.28)。
  • 幸存者复发静脉血栓栓塞(比值比0.76,95%CI 0.49-1.19)和大出血(比值比1.07,95%CI 0.77-1.47)在高、低容量医院间无显著差异。
  • 高容量医院收治的急性症状性肺栓塞患者合并症负担更高。

适用人群与场景

  • 16个国家353家医院连续纳入的39 257例确诊急性症状性肺栓塞患者,登记时间为2001年1月1日至2018年8月31日。

研究设计与关键结果

  • 跨国基于人群队列研究,使用RIETE登记库数据,纳入16个国家353家医院39 257例连续确诊急性症状性肺栓塞患者,评估医院年肺栓塞病例量与30天肺栓塞相关死亡的关系。
  • 高容量医院(>40例/年)患者合并症负担更高;年医院病例量与肺栓塞相关死亡呈显著负相关。
  • 最高四分位(>40例/年)较最低四分位(<15例/年)调整后30天肺栓塞相关死亡风险降低44%(调整风险1.3% vs 2.3%;调整比值比0.56,95%CI 0.33-0.95;P=0.03),所有敏感性分析结果一致。
  • 30天全因死亡在高、低容量医院间无显著差异(调整比值比0.78,95%CI 0.50-1.22;P=0.28)。
  • 幸存者复发静脉血栓栓塞(比值比0.76,95%CI 0.49-1.19)和大出血(比值比1.07,95%CI 0.77-1.47)在高、低容量医院间无显著差异。

证据类型、等级与局限

  • 证据类型:跨国基于人群队列研究(使用RIETE登记库数据)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,高容量医院收治与急性症状性肺栓塞患者30天肺栓塞相关死亡降低相关,这些发现可能对管理策略有启示。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the association between experience in the management of acute pulmonary embolism, reflected by hospital case volume, and mortality.

DESIGN: Multinational population based cohort study using data from the Registro Informatizado de la Enfermedad TromboEmbólica (RIETE) registry between 1 January 2001 and 31 August 2018.

SETTING: 353 hospitals in 16 countries.

PARTICIPANTS: 39 257 consecutive patients with confirmed diagnosis of acute symptomatic pulmonary embolism.

MAIN OUTCOME MEASURE: Pulmonary embolism related mortality within 30 days after diagnosis of the condition.

RESULTS: Patients with acute symptomatic pulmonary embolism admitted to high volume hospitals (>40 pulmonary embolisms per year) had a higher burden of comorbidities. A significant inverse association was seen between annual hospital volume and pulmonary embolism related mortality. Admission to hospitals in the highest quarter (that is, >40 pulmonary embolisms per year) was associated with a 44% reduction in the adjusted odds of pulmonary embolism related mortality at 30 days compared with admission to hospitals in the lowest quarter (<15 pulmonary embolisms per year; adjusted risk 1.3% v 2.3%; adjusted odds ratio 0.56 (95% confidence interval 0.33 to 0.95); P=0.03). Results were consistent in all sensitivity analyses. All cause mortality at 30 days was not significantly reduced between the two quarters (adjusted odds ratio 0.78 (0.50 to 1.22); P=0.28). Survivors showed little change in the odds of recurrent venous thromboembolism (odds ratio 0.76 (0.49 to 1.19)) or major bleeding (1.07 (0.77 to 1.47)) between the low and high volume hospitals.

CONCLUSIONS: In patients with acute symptomatic pulmonary embolism, admission to high volume hospitals was associated with significant reductions in adjusted pulmonary embolism related mortality at 30 days. These findings could have implications for management strategies.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Jiménez D, Bikdeli B, Quezada A, et al. Hospital volume and outcomes for acute pulmonary embolism: multinational population based cohort study. BMJ. 2019. PMID: 31358508. doi:10.1136/bmj.l4416

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。